FY2025 EPS Estimates for Core Scientific Cut by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ) – Investment analysts at Roth Capital decreased their FY2025 earnings per share estimates for shares of Core Scientific in a report released on Tuesday, January 7th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings of ($0.30) per share for the year, down from their previous estimate of ($0.29). Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.50 per share. Roth Capital also issued estimates for Core Scientific’s Q4 2025 earnings at ($0.01) EPS and FY2026 earnings at $0.33 EPS.

CORZ has been the topic of a number of other research reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $20.00 price target on shares of Core Scientific in a research note on Thursday, October 3rd. B. Riley lifted their target price on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Macquarie increased their price target on shares of Core Scientific from $16.00 to $19.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th. BTIG Research lifted their price objective on Core Scientific from $19.00 to $20.00 and gave the company a “buy” rating in a report on Monday, December 16th. Finally, Needham & Company LLC increased their target price on Core Scientific from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Thirteen investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Core Scientific presently has an average rating of “Buy” and a consensus price target of $18.46.

Core Scientific Price Performance

Shares of Core Scientific stock opened at $14.04 on Thursday. The company has a market cap of $3.92 billion and a PE ratio of -2.60. The firm has a fifty day moving average price of $15.66 and a two-hundred day moving average price of $12.61. Core Scientific has a fifty-two week low of $2.61 and a fifty-two week high of $18.63.

Insiders Place Their Bets

In related news, insider Todd M. Duchene sold 25,000 shares of Core Scientific stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total transaction of $427,500.00. Following the completion of the transaction, the insider now owns 1,661,474 shares in the company, valued at approximately $28,411,205.40. This trade represents a 1.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Adam Taylor Sullivan sold 88,380 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,258,531.20. Following the transaction, the chief executive officer now directly owns 4,128,505 shares in the company, valued at approximately $58,789,911.20. This trade represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 348,241 shares of company stock valued at $5,436,802 in the last quarter. 32.00% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Core Scientific

Several institutional investors and hedge funds have recently modified their holdings of CORZ. P Schoenfeld Asset Management LP acquired a new stake in Core Scientific during the second quarter worth about $4,185,000. Mirabella Financial Services LLP acquired a new stake in shares of Core Scientific during the 3rd quarter worth approximately $18,383,000. Highland Peak Capital LLC increased its stake in Core Scientific by 37.9% in the third quarter. Highland Peak Capital LLC now owns 413,584 shares of the company’s stock valued at $4,905,000 after acquiring an additional 113,584 shares during the last quarter. Van ECK Associates Corp raised its position in Core Scientific by 22.9% during the third quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company’s stock valued at $19,177,000 after purchasing an additional 300,942 shares in the last quarter. Finally, Capstone Investment Advisors LLC lifted its stake in Core Scientific by 113.4% during the third quarter. Capstone Investment Advisors LLC now owns 55,000 shares of the company’s stock worth $652,000 after purchasing an additional 29,230 shares during the last quarter.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.